GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Porton Pharma Solutions Ltd (SZSE:300363) » Definitions » Total Current Assets

Porton Pharma Solutions (SZSE:300363) Total Current Assets : ¥3,115 Mil (As of Jun. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Porton Pharma Solutions Total Current Assets?

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Porton Pharma Solutions's total current assets for the quarter that ended in Jun. 2024 was ¥3,115 Mil.


Porton Pharma Solutions Total Current Assets Historical Data

The historical data trend for Porton Pharma Solutions's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Porton Pharma Solutions Total Current Assets Chart

Porton Pharma Solutions Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Current Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,926.52 2,181.38 3,210.93 5,462.55 3,654.32

Porton Pharma Solutions Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Total Current Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4,248.84 3,652.63 3,654.32 3,441.02 3,115.40

Porton Pharma Solutions Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Porton Pharma Solutions's Total Current Assets for the fiscal year that ended in Dec. 2023 is calculated as

Porton Pharma Solutions's Total Current Assets for the quarter that ended in Jun. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.


Porton Pharma Solutions  (SZSE:300363) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Porton Pharma Solutions's Liquidation Value for the quarter that ended in Jun. 2024 is

Liquidation value
= Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=1483.01-3288.346+0.75 * 634.573+0.5 * 780.712
=-939

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Porton Pharma Solutions Total Current Assets Related Terms

Thank you for viewing the detailed overview of Porton Pharma Solutions's Total Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Porton Pharma Solutions Business Description

Traded in Other Exchanges
N/A
Address
Fangzheng Avenue, Porton New Drug Outsourcing Service and R&D Center, Shuitu, Beibei District, Chongqing, CHN, 400714
Porton Pharma Solutions Ltd is a China-based external manufacturing supplier of custom drug intermediates and Active Pharmaceutical Ingredients (APIs) to pharmaceutical companies. It is engaged in the process development activities and pilot-scale and commercial-scale manufacturing activities.
Executives
Wang Zhong Neng Executives
Yu Yong Mei Executives
Sun Min Executives
Ji Yao Hui Executives
Ju Nian Feng Directors, executives
Tan Jun Supervisors
Xu Ai Wu Directors, executives
Guo Yong Qing Independent director
Director
Director
Ceng Hui Supervisors
Chen Bei Executives

Porton Pharma Solutions Headlines

No Headlines